Overview
What is Licr Fund Inc?
Licr Fund Inc is a non-profit Delaware corporation based in New York City, specifically at 600 Third Avenue, 32nd Floor. The organization holds a diverse investment portfolio, with annual proceeds allocated to support the Ludwig Institute for Cancer Research Ltd. This institute is a tax-exempt entity under IRC section 501(c)(3) and is not classified as a private foundation due to its role in conducting medical research into cancer, in collaboration with qualified hospitals. In 2022, the Licr Fund Inc granted $76 million to the institute, which was utilized for laboratory research and clinical trials. The Licr Fund Inc functions as a supporting organization, contributing financially to the Ludwig Institute for Cancer Research Ltd's mission.
Official website here: www.ludwigcancerresearch.org/about/
Is Licr Fund Inc legitimate?
Licr Fund Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Licr Fund Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $245,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.ludwigcancerresearch.org/about/
What is the mission statement of Licr Fund Inc?
Licr Fund Inc is a non-profit organization that supports the Ludwig Institute for Cancer Research Ltd. by providing grants and assistance to further the Institute's mission in medical research. The Fund holds a diverse investment portfolio, the proceeds of which are used to provide annual financial support to the Institute. In 2022, the Fund granted $76 million to the Institute to aid in their research activities, specifically laboratory research and clinical trials. As a medical research organization, the Institute is exempt under IRC section 501(C)(3) and conducts research into the causes and cures of cancer, collaborating with qualified hospitals. The Fund's contributions play a crucial role in advancing the Institute's groundbreaking work in cancer research.
Official website here: www.ludwigcancerresearch.org/about/
Who is the CEO of Licr Fund Inc?
Xing Chen is the President, Cio of Licr Fund Inc.
Official website here: www.ludwigcancerresearch.org/about/
What is the revenue of Licr Fund Inc?
Licr Fund Inc's revenue in 2022 was $69,314,681.
Official website here: www.ludwigcancerresearch.org/about/
Who are the executives of Licr Fund Inc and what are their salaries?
- Xing Chen (President, Cio)
- Dr Chi Van Dang (Director)
- Edward A Mcdermott Jr (Director)
- Avantika Patel (Vice President)
- Christopher T Conroy (Treasurer)
- Alexander Borissov (Secretary)
- John L Notter (Director, Board Chairperson)
- John D Gordan Iii (Director)
- Olivier Dunant (Director, Vice Chairperson)
- Judge Barbara S Jones (Director)
- Dr Nancy Ellen Davidson (Director)
- Alexandra Johnson (Director)
- Dr Philip A Pizzo (Director (To Aug. 2022))
Official website here: www.ludwigcancerresearch.org/about/
Where can I find the form 990 for Licr Fund Inc?
The Licr Fund Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.ludwigcancerresearch.org/about/
Learn more at the official website: www.ludwigcancerresearch.org/about/
Mission Statement of Licr Fund Inc
LICR Fund Inc, a supporting organization, plays a significant role in furthering the mission of the Ludwig Institute for Cancer Research Ltd. This non-profit Delaware corporation holds a diverse investment portfolio that generates annual funds to support the Institute's groundbreaking medical research endeavors. The Ludwig Institute for Cancer Research, exempt under IRC section 501(c)(3), is not classified as a private foundation due to its status as a medical research organization, engaged in cancer research in conjunction with qualified hospitals.
In 2022, Licr Fund Inc granted the Ludwig Institute for Cancer Research a substantial sum of $76 million, utilized to bolster their research initiatives, including laboratory research and clinical trials. As a philanthropic entity, Licr Fund Inc's primary objective is to assist the Institute in its quest to unravel the mysteries of cancer, ultimately contributing to the discovery of potential cures. By providing financial support, Licr Fund Inc enables the Institute to continue pushing the boundaries of scientific knowledge and making strides in the cancer research field.
Impact
This information is meant to be a general summary of Licr Fund Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Licr Fund Inc's impact lies in its crucial support of the Ludwig Institute for Cancer Research Ltd, a medical research organization dedicated to investigating the causes and cures of cancer. By providing substantial annual grants and assistance totaling $76,000,000 in 2022, Licr Fund Inc plays a vital role in advancing crucial medical research activities, including laboratory investigations and clinical trials. Through its unwavering commitment to funding cancer research, Licr Fund Inc directly contributes to the global efforts to combat this devastating disease, potentially leading to groundbreaking discoveries that can improve the lives of cancer patients worldwide.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
1990
Phone
(212) 450-1500
Principal Officer
Xing Chen
Main Address
600 THIRD AVENUE 32ND FLOOR, NEW YORK, NY, 10016
NTEE Category
Code: H30 - Medical research
If you are a representative of Licr Fund Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.